Overview

Efficacy of 851B Gel for Treating High-Risk Cervical Human Papillomavirus Infection in Women.

Status:
Terminated
Trial end date:
2008-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to evaluate efficacy of 851B gel over a range of concentrations and dosing regimens on high-risk cervical human papillomavirus infection in women.
Phase:
Phase 2
Details
Lead Sponsor:
Takeda